✦ LIBER ✦

PDB10: ECONOMIC OUTCOMES OF HMG CoA REDUCTASE INHIBITORS IN A HYPERTENSIVE DIABETIC POPULATION IN A MANAGED CARE ORGANIZATION

✍ Scribed by TJ White; M Juzba; DM Berenbeim; AM Gilderman; JC Salas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

C4. Cost-effectiveness trends of HMG-CoA

✍ A. Petitta; R.E. Ward; J.V. Anandan; S.J. Beis; A.M. Johnson 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 154 KB

PCV35: COST EFFECTIVENESS ANALYSIS OF HM

✍ EA MacLean; CM Moffitt 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PNP4: ECONOMIC OUTCOMES OF ANTIDEPRESSAN

✍ TJ White; MB Nichol 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PRS10 ECONOMIC AND CLINICAL OUTCOMES OF

✍ J Prescott 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PRS8: ECONOMIC OUTCOMES OF STEROID INHAL

✍ TJ White; M Juzba; DM Berenbeim; AM Gilderman; JC Salas 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PAR2: EFFECTS OF A PRIOR AUTHORIZATION P

✍ DM Hartung; DR Touchette; K Ketchum; DG Haxby 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB